Skip to content
clomipramine

Structure via PubChem · Public domain (PubChem)

EntityQ58713· pop 37· linked from 2,844 articles

clomipramine

Sign in to save

Also known as 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine, 3-chloroimipramine, chlorimipramine, monochlorimipramine, 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine

Clomipramine, sold under the brand name Anafranil among others, is a tricyclic antidepressant (TCA). It is used in the treatment of various conditions, most notably obsessive–compulsive disorder but also many other disorders, including hyperacusis, panic disorder, major depressive disorder, trichotillomania, body dysmorphic disorder and chronic pain. It has also been notably used to treat premature ejaculation and the cataplexy associated with narcolepsy.

OverviewAI-generated

Clomipramine is a chemical compound with the formula C₁₉H₂₃ClN₂. Its IUPAC name is 3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine. The molecule has a mass of 314.155 and a weight of 314.9. It features a charge of 0, two hydrogen bond acceptors, and no hydrogen bond donors. The compound's xlogp value is 5.2, and its topological polar surface area is 6.5.

The stylized name for the substance is clomiPRAMINE. It is associated with a Commons category titled "Clomipramine." In scientific literature, there are 4256 PubMed entries related to clomipramine. Additionally, the subject is referenced by 2,844 other encyclopedia articles.

Synthesized by Vinony from 18 facts across 4 sources: Wikidata, PubMed, PubChem, Vinony graph. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.

Key facts

Drug.Watchedfields
changed
Drug.verifiedrevid
459591021
Drug.image
Clomipramine2DACS.svg
Drug.image_class
skin-invert-image
Drug.alt
Skeletal formula of clomipramine
Drug.width
200
Drug.image2
Clomipramine-3D-balls.png
Drug.image_class2
bg-transparent
Drug.alt2
Ball-and-stick model of the clomipramine molecule
Drug.width2
200
Drug.tradename
Anafranil, Clomicalm, others
Drug.MedlinePlus
a697002
Drug.DailyMedID
Clomipramine
Drug.pregnancy_AU
C
Drug.routes_of_administration
By mouth, intravenous
Drug.ATC_prefix
N06
Drug.ATC_suffix
AA04
Drug.legal_AU
S4

via Wikipedia infobox

Chemical data

Formula
C19H23ClN2
Molecular weight
314.9 g/mol
IUPAC name
3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine
SMILES
CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
InChIKey
GDLIGKIOYRNHDA-UHFFFAOYSA-N
XLogP
5.2
Polar surface area
6.5 Ų
H-bond donors
0
H-bond acceptors
2
Formal charge
0

via PubChem

Research

4,256 papers

via PubMed

Wikidata facts

Mass
314.155
Has use
medication
Show 9 more facts
chemical formula
C₁₉H₂₃ClN₂
significant drug interaction
enalapril
Commons category
Clomipramine
canonical SMILES
CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
World Health Organisation international non-proprietary name
clomipramine
medical condition treated
obsessive-compulsive disorder
subject has role
essential medicine
physically interacts with
solute carrier family 6 member 4
stylized name
clomiPRAMINE
Sources (9)

via Wikidata · CC0

~33 min read

Encyclopedic overview

19 sections
Contents
  • Medical uses
  • Contraindications
  • Pregnancy and lactation
  • Side effects
  • Withdrawal
  • Overdose
  • Interactions
  • Pharmacology
  • Pharmacodynamics
  • Serotonergic activity
  • Obsessive–compulsive disorder
  • Pharmacokinetics
  • Chemistry
  • History
  • Society and culture
  • Generic names
  • Brand names
  • Veterinary uses
  • References

Clomipramine, sold under the brand name Anafranil among others, is a tricyclic antidepressant (TCA). It is used in the treatment of various conditions, most notably obsessive–compulsive disorder but also many other disorders, including hyperacusis, panic disorder, major depressive disorder, trichotillomania, body dysmorphic disorder and chronic pain. It has also been notably used to treat premature ejaculation and the cataplexy associated with narcolepsy.

It may also address certain fundamental features surrounding narcolepsy besides cataplexy (especially hypnagogic and hypnopompic hallucinations). The evidence behind this, however, is less robust. As with other antidepressants (notably including selective serotonin reuptake inhibitors), it may paradoxically increase the risk of suicide in those under the age of 25, at least in the first few weeks of treatment.

Excerpted from Wikipedia’s “clomipramine” article, available under the CC BY-SA 4.0 licence.